Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsunefusa Hayashida

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Scientific Reports|November 29, 2025
Virological outcomes and treatment retention in North Vietnam amidst transition to social insurance-based HIV services and dolutegravir-based regimensShoko Matsumoto, Moeko Nagai, Linh Khanh Tran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26Hiroyuki Gatanaga, Tsunefusa Hayashida, Kiyoto Tsuchiya, et al.
The Journal of Antimicrobial Chemotherapy|October 19, 2023
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective studyShunsuke Uno, Hiroyuki Gatanaga, Tsunefusa Hayashida, et al.
Antiviral Research|August 10, 2010
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in JapanJunko Hattori, Teiichiro Shiino, Hiroyuki Gatanaga, et al.
AIDS (London, England)|June 27, 2017
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infectionHiroyuki Gatanaga, Zabrina L Brumme, Emily Adland, et al.
Journal of the International AIDS Society|May 24, 2023
Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance NetworkMachiko Otani, Teiichiro Shiino, Atsuko Hachiya, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Scientific Reports|November 29, 2025
Virological outcomes and treatment retention in North Vietnam amidst transition to social insurance-based HIV services and dolutegravir-based regimensShoko Matsumoto, Moeko Nagai, Linh Khanh Tran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2007
Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26Hiroyuki Gatanaga, Tsunefusa Hayashida, Kiyoto Tsuchiya, et al.
The Journal of Antimicrobial Chemotherapy|October 19, 2023
Virological outcomes of various first-line ART regimens in patients harbouring HIV-1 E157Q integrase polymorphism: a multicentre retrospective studyShunsuke Uno, Hiroyuki Gatanaga, Tsunefusa Hayashida, et al.
Antiviral Research|August 10, 2010
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in JapanJunko Hattori, Teiichiro Shiino, Hiroyuki Gatanaga, et al.
AIDS (London, England)|June 27, 2017
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infectionHiroyuki Gatanaga, Zabrina L Brumme, Emily Adland, et al.
Journal of the International AIDS Society|May 24, 2023
Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance NetworkMachiko Otani, Teiichiro Shiino, Atsuko Hachiya, et al.
Pageof 4